{
  "resourceType": "ValueSet",
  "id": "2.16.840.1.113883.3.464.1003.110.12.1044-20170504",
  "meta": {
    "versionId": "20",
    "lastUpdated": "2023-12-21T17:43:03.000-05:00",
    "profile": [ "http://hl7.org/fhir/StructureDefinition/shareablevalueset", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm" ]
  },
  "extension": [ {
    "url": "http://hl7.org/fhir/StructureDefinition/valueset-author",
    "valueContactDetail": {
      "name": "NCQA PHEMUR Author"
    }
  }, {
    "url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
    "valueDate": "2025-03-10"
  }, {
    "url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
    "valueDate": "2017-05-04"
  } ],
  "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.12.1044",
  "identifier": [ {
    "system": "urn:ietf:rfc:3986",
    "value": "urn:oid:2.16.840.1.113883.3.464.1003.110.12.1044"
  } ],
  "version": "20170504",
  "name": "ChildInfluenzaVaccineAdministered",
  "title": "Child Influenza Vaccine Administered",
  "status": "active",
  "experimental": false,
  "date": "2022-03-07T11:14:02-05:00",
  "publisher": "NCQA PHEMUR",
  "jurisdiction": [ {
    "extension": [ {
      "url": "http://hl7.org/fhir/StructureDefinition/data-absent-reason",
      "valueCode": "unknown"
    } ]
  } ],
  "purpose": "(Clinical Focus: The purpose of this value set is to represent concepts for an influenza vaccination for use in children 2 and younger.),(Data Element Scope: This value set may use a model element related to Procedure.),(Inclusion Criteria: Includes concepts that represent an influenza vaccination for use in children 2 and younger.),(Exclusion Criteria: Excludes influenza vaccines not recommended for use in children 2 and younger.)",
  "compose": {
    "include": [ {
      "valueSet": [ "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.11.1116" ]
    }, {
      "valueSet": [ "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.11.1115" ]
    } ]
  },
  "expansion": {
    "identifier": "urn:uuid:b24f8501-b1a3-4736-a1d8-bbde6521b040",
    "timestamp": "2025-06-20T17:00:15-04:00",
    "total": 12,
    "offset": 0,
    "parameter": [ {
      "name": "count",
      "valueInteger": 1000
    }, {
      "name": "offset",
      "valueInteger": 0
    } ],
    "contains": [ {
      "system": "http://snomed.info/sct",
      "version": "http://snomed.info/sct/731000124108/version/20230901",
      "code": "86198006",
      "display": "Administration of vaccine product containing only Influenza virus antigen (procedure)"
    }, {
      "system": "http://www.ama-assn.org/go/cpt",
      "version": "2024",
      "code": "90655",
      "display": "Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.25 mL dosage, for intramuscular use"
    }, {
      "system": "http://www.ama-assn.org/go/cpt",
      "version": "2024",
      "code": "90657",
      "display": "Influenza virus vaccine, trivalent (IIV3), split virus, 0.25 mL dosage, for intramuscular use"
    }, {
      "system": "http://www.ama-assn.org/go/cpt",
      "version": "2024",
      "code": "90661",
      "display": "Influenza virus vaccine, trivalent (ccIIV3), derived from cell cultures, subunit, preservative and antibiotic free, 0.5 mL dosage, for intramuscular use"
    }, {
      "system": "http://www.ama-assn.org/go/cpt",
      "version": "2024",
      "code": "90673",
      "display": "Influenza virus vaccine, trivalent (RIV3), derived from recombinant DNA, hemagglutinin (HA) protein only, preservative and antibiotic free, for intramuscular use"
    }, {
      "system": "http://www.ama-assn.org/go/cpt",
      "version": "2024",
      "code": "90674",
      "display": "Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, preservative and antibiotic free, 0.5 mL dosage, for intramuscular use"
    }, {
      "system": "http://www.ama-assn.org/go/cpt",
      "version": "2024",
      "code": "90685",
      "display": "Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.25 mL dosage, for intramuscular use"
    }, {
      "system": "http://www.ama-assn.org/go/cpt",
      "version": "2024",
      "code": "90686",
      "display": "Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use"
    }, {
      "system": "http://www.ama-assn.org/go/cpt",
      "version": "2024",
      "code": "90687",
      "display": "Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.25 mL dosage, for intramuscular use"
    }, {
      "system": "http://www.ama-assn.org/go/cpt",
      "version": "2024",
      "code": "90688",
      "display": "Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use"
    }, {
      "system": "http://www.ama-assn.org/go/cpt",
      "version": "2024",
      "code": "90689",
      "display": "Influenza virus vaccine, quadrivalent (IIV4), inactivated, adjuvanted, preservative free, 0.25 mL dosage, for intramuscular use"
    }, {
      "system": "http://www.ama-assn.org/go/cpt",
      "version": "2024",
      "code": "90756",
      "display": "Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, antibiotic free, 0.5 mL dosage, for intramuscular use"
    } ]
  }
}